U.K. Limits AstraZeneca Covid-19 Vaccine to Over-30s Amid Blood-Clot Concerns
The U.K.’s vaccines advisory body said the Covid-19 vaccine produced by AstraZeneca PLC should preferably not be given to people...
Health Care/Life Sciences
Facebook, Apple and Niantic Bet People Are Ready for Augmented-Reality Glasses
Tech companies are accelerating their development of computerized glasses for consumers, in a competition between Facebook Inc., Apple Inc. and...
Airlines Want Vaccine Passports but Don’t Want to Pay for Them
LONDON—Airlines are resisting early European Union plans that could push some of the costs and responsibility for implementing vaccination passports...
FTC Seeks to Block Illumina’s $7.1 Billion Acquisition of Life Sciences Firm Grail
WASHINGTON—The Federal Trade Commission filed suit Tuesday to block Illumina Inc.’s planned $7.1 billion acquisition of a company developing an...
Germany Restricts Use of AstraZeneca Vaccine for Under-60s
BERLIN—Germany’s government said Tuesday it will restrict the use of the AstraZeneca PLC’s Covid-19 vaccine for people younger than 60...
IMF Sees Brighter Outlook for Global Economy
WASHINGTON—The International Monetary Fund is preparing to raise its forecasts for the global economy in 2021 and 2022 thanks to...
Pair of Covid-19 Drugs Performed Well in Studies, Makers Say
A pair of experimental Covid-19 treatments produced positive results in clinical trials, the companies developing the drugs said Monday. Humanigen...
WSJ News Exclusive | CM Life Sciences II SPAC Nears Deal to Combine With SomaLogic
A special-purpose acquisition company focused on life sciences and backed by a well-known shareholder activist is nearing a deal to...
AstraZeneca Releases Covid-19 Vaccine Data Showing 76% Efficacy
AstraZeneca PLC released more pivotal-trial data for its Covid-19 vaccine, saying the shot was 76% effective at preventing Covid-19 with...
EU Proposes to Make It Easier to Ban Vaccine Exports
BRUSSELS—The European Union is set to put in place a plan that would make it easier for the bloc’s governments...
U.S. Health Officials Raise Concerns Over AstraZeneca Vaccine Data
U.S. officials said early Tuesday they had been told AstraZeneca PLC may have released outdated information in its disclosure of...
AstraZeneca’s Covid-19 Vaccine Is Safe, 79% Effective in Late-Stage U.S. Trials
AstraZeneca AZN -0.24% PLC’s Covid-19 vaccine was shown to be safe and 79% effective in preventing symptomatic disease in U.S....
As U.S. Economic Outlook Brightens, Europe Fears a Cloudy Summer
A rapid Covid-19 vaccination campaign in the U.S. holds the promise that millions of Americans can return to beach vacations,...
Founders of Bankrupt Startup UBiome Indicted in Fraud Case
The former co-chief executives of bankrupt lab-testing startup uBiome Inc. were charged with healthcare and securities fraud among other offenses,...
AstraZeneca’s Covid-19 Vaccine Cleared by EU After Blood-Clot Concerns
The European Union’s health agency said that the Covid-19 vaccine produced by AstraZeneca PLC was “safe and effective” and didn’t...
AstraZeneca Covid-19 Vaccine’s Benefits Outweigh Risks, Says EU
The European Union’s health authority said it is still firmly convinced that the benefits of AstraZeneca PLC’s Covid-19 vaccine outweigh...
Lilly Alzheimer’s Drug Shows Modest Benefit in Clinical Trial
An Eli Lilly LLY 1.40% & Co. experimental drug modestly slowed the cognitive and functional decline of early-stage Alzheimer’s patients...
Biden Tells States to Make All Adults Eligible for Covid-19 Vaccine by May 1
WASHINGTON—President Biden called on states to make all adults in the U.S. eligible for Covid-19 vaccines by May 1 and...
As Covid-19 Vaccine Eligibility Expands, Interest Could Wane
Mandatory Credit: Photo by CRISTOBAL HERRERA-ULASHKEVICH/EPA-EFE/Shutterstock (11784205g) People queue in a line to get the COVID-19 Vaccine at the new...
WSJ News Exclusive | Oxford-AstraZeneca Covid-19 Vaccine Startup in Conflict With University Ahead of Planned IPO
A startup behind the Covid-19 vaccine developed by the University of Oxford and AstraZeneca AZN 1.76% PLC is planning an...
